We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong at PhilMedical 2023 Expo | More to Expect!

By LabMedica International staff writers
Posted on 19 Sep 2023
From 23 to 25 August 2023, the MEDICAL PHILIPPINES 2023 Expo was held at the SMX Convention Center in Manila, Philippines. More...
As the largest and most professional medical devices expo in Philippines, it attracted the participation of many famous companies in the industry. As an innovative leader in the field of molecular diagnostics in China, Tianlong Technology showcased its advanced technology, products and solutions, as well as professional services on this expo.

At the exhibition, Tianlong’s Panall 8000 All-in-one Molecular Diagnosis System, which can realize "joint detection of multiple pathogens", the compact and flexible Gentier Mini Series Portable Real Time PCR System, as well as the GeneFlex Automatic Nucleic Acid Extractor, received wide attention from the visitors.

On the first day of the expo, the head of Department of Emergency Medical and Trauma Services, Hospital Kuala Lumpur visited Tianlong’s booth and had a deep communication with Tianlong processionals. Hospital Kuala Lumpur is now the largest hospital under the Ministry of Health of Malaysia and is considered to be one of the biggest hospital in Asia.

During the expo, Tianlong's professional team had deep communication with customers, introducing and demonstrating product features, technical advantages and service system.

Tianlong not only achieved good attention on the exhibition, but also developed cooperation opportunities, opening up new channels and opportunities for the future development of the enterprise.

The successful participation in the expo is also an important step in Tianlong's globalization strategy. As an enterprise actively expanding overseas markets, Tianlong will continue to look at the global market and work with more international partners to promote the development of medical technology.

Stay tuned for Tianlong’s following two expos in Thailand this coming September!

Thailand LAB International
Booth No. 3G17
Dates: Sep 6 to 8, 2023
Venue: BITEC, Bangkok, Thailand

Medical Fair Thailand
Booth No. T05
Dates: Sep 13 to 15, 2023
Venue: BITEC, Bangkok, Thailand



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Creatine Kinase-MB Assay
CK-MB Test
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.